An integrated view of suppressor T cell subsets in immunoregulation.

The immune system evolved to protect organisms from a virtually infinite variety of disease-causing agents but to avoid harmful responses to self. Because immune protective mechanisms include the elaboration of potent inflammatory molecules, antibodies, and killer cell activation--which together can not only destroy invading microorganisms, pathogenic autoreactive cells, and tumors, but also mortally injure normal cells--the immune system is inherently a "double-edged sword" and must be tightly regulated. Immune response regulation includes homeostatic mechanisms intrinsic to the activation and differentiation of antigen-triggered immunocompetent cells and extrinsic mechanisms mediated by suppressor cells. This review series will focus on recent advances indicating that distinct subsets of regulatory CD4+ and CD8+ T cells as well as NK T cells control the outgrowth of potentially pathogenic antigen-reactive T cells and will highlight the evidence that these suppressor T cells may play potentially important clinical roles in preventing and treating immune-mediated disease. Here we provide a historical overview of suppressor cells and the experimental basis for the existence of functionally and phenotypically distinct suppressor subsets. Finally, we will speculate on how the distinct suppressor cell subsets may function in concert to regulate immune responses.

[1]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[2]  S. Durham,et al.  Tregs and allergic disease. , 2004, The Journal of clinical investigation.

[3]  A. O’Garra,et al.  IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. , 2004, The Journal of clinical investigation.

[4]  L. Turka,et al.  Tregs and transplantation tolerance. , 2004, The Journal of clinical investigation.

[5]  Vipin Kumar,et al.  Homeostatic control of immunity by TCR peptide-specific Tregs. , 2004, The Journal of clinical investigation.

[6]  Irun R Cohen,et al.  Tregs in T cell vaccination: exploring the regulation of regulation. , 2004, The Journal of clinical investigation.

[7]  Linrong Lu,et al.  Qa-1 restriction of CD8+ suppressor T cells. , 2004, The Journal of clinical investigation.

[8]  S. Sakaguchi,et al.  CD4+ Tregs and immune control. , 2004, The Journal of clinical investigation.

[9]  D. Mancini,et al.  Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. , 2004, International immunology.

[10]  A. O’Garra,et al.  Regulatory T cells and mechanisms of immune system control , 2004, Nature Medicine.

[11]  C. Piccirillo,et al.  Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. , 2004, Trends in immunology.

[12]  M. Shinohara,et al.  Analysis of regulatory CD8 T cells in Qa-1-deficient mice , 2004, Nature Immunology.

[13]  K. Wucherpfennig,et al.  Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. , 2004, The Journal of clinical investigation.

[14]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[15]  L. Cosmi,et al.  Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. , 2003, Blood.

[16]  S. Ziegler,et al.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. , 2003, The Journal of clinical investigation.

[17]  S. Khoury,et al.  Regulatory functions of CD8+CD28- T cells in an autoimmune disease model. , 2003, The Journal of clinical investigation.

[18]  G. Martino,et al.  Activation of invariant NKT cells by αGalCer administration protects mice from MOG35–55‐induced EAE: critical roles for administration route and IFN‐γ  , 2003 .

[19]  L. Chess,et al.  Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor Vβ repertoire during experimental autoimmune encephalomyelitis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[21]  S. Sakaguchi Control of Immune Responses by Naturally Arising CD4+ Regulatory T Cells That Express Toll-like Receptors , 2003, The Journal of experimental medicine.

[22]  M. A. Curotto de Lafaille,et al.  CD4(+) regulatory T cells in autoimmunity and allergy. , 2002, Current opinion in immunology.

[23]  L. Teyton,et al.  Testing the NKT cell hypothesis of human IDDM pathogenesis. , 2002, The Journal of clinical investigation.

[24]  L. Klein,et al.  Origin of regulatory T cells with known specificity for antigen , 2002, Nature Immunology.

[25]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[26]  S. Sharif,et al.  Regulatory Natural Killer T Cells Protect against Spontaneous and Recurrent Type 1 Diabetes , 2002, Annals of the New York Academy of Sciences.

[27]  L. Teyton,et al.  Distinct Functional Lineages of Human Vα24 Natural Killer T Cells , 2002, The Journal of experimental medicine.

[28]  M. Colonna,et al.  Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.

[29]  Michael T. Wilson,et al.  Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.

[30]  L. Chess,et al.  Induction of TCR Vβ-Specific CD8+ CTLs by TCR Vβ-Derived Peptides Bound to HLA-E1 , 2001, The Journal of Immunology.

[31]  M. Kronenberg,et al.  Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes , 2001, Nature Medicine.

[32]  E. Shevach,et al.  Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells , 2001, The Journal of Immunology.

[33]  E. Shevach,et al.  Control of T‐cell activation by CD4+ CD25+ suppressor T cells , 2001, Immunological reviews.

[34]  M. A. Curotto de Lafaille,et al.  Regulatory T cells in spontaneous autoimmune encephalomyelitis , 2001, Immunological reviews.

[35]  E. Shevach Certified Professionals , 2001, The Journal of experimental medicine.

[36]  L. Chess,et al.  CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Roncarolo,et al.  The role of different subsets of T regulatory cells in controlling autoimmunity. , 2000, Current opinion in immunology.

[38]  P. Kourilsky,et al.  Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. , 2000, Immunity.

[39]  M. Smyth,et al.  NKT cells: facts, functions and fallacies. , 2000, Immunology today.

[40]  T. Mak,et al.  Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.

[41]  M. Roncarolo,et al.  T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. , 2000, The Journal of allergy and clinical immunology.

[42]  S. Sakaguchi Regulatory T cells , 2000, Cell.

[43]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[44]  R. Flavell,et al.  Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease , 2000 .

[45]  Ethan M. Shevach,et al.  Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific , 2000, The Journal of Immunology.

[46]  N. Sarvetnick,et al.  A Defect in Interleukin 12–Induced Activation and Interferon γ Secretion of Peripheral Natural Killer T Cells in Nonobese Diabetic Mice Suggests New Pathogenic Mechanisms for Insulin-Dependent Diabetes Mellitus , 1999, The Journal of experimental medicine.

[47]  Y. Zhai,et al.  What is the role of regulatory T cells in transplantation tolerance? , 1999, Current opinion in immunology.

[48]  H. Macdonald,et al.  Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. , 1999, Journal of immunology.

[49]  M. Davis,et al.  A kinetic basis for T cell receptor repertoire selection during an immune response. , 1999, Immunity.

[50]  D. Mason,et al.  Regulatory T Cells in the Control of Autoimmunity: the Essential Role of  Transforming Growth Factor β and Interleukin 4 in the Prevention of Autoimmune Thyroiditis in Rats by Peripheral CD4+CD45RC− Cells and CD4+CD8− Thymocytes , 1999, The Journal of experimental medicine.

[51]  S. Tonegawa,et al.  CD4+ T Cells Prevent Spontaneous Experimental Autoimmune Encephalomyelitis in Anti–Myelin Basic Protein T Cell Receptor Transgenic Mice , 1998, The Journal of experimental medicine.

[52]  S. Lederman,et al.  Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro. , 1998, Human immunology.

[53]  J. Lafaille The role of helper T cell subsets in autoimmune diseases. , 1998, Cytokine & growth factor reviews.

[54]  L. Chess,et al.  T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[55]  D. Godfrey,et al.  α/β–T Cell Receptor (TCR)+CD4−CD8− (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 , 1998, The Journal of experimental medicine.

[56]  J. Niederkorn,et al.  A Novel Role for TGF-β and IL-10 in the Induction of Immune Privilege , 1998, The Journal of Immunology.

[57]  D. Hafler,et al.  Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes , 1998, Nature.

[58]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[59]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[60]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997 .

[61]  S. Balk,et al.  Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells , 1997, The Journal of experimental medicine.

[62]  D. Godfrey,et al.  Association between alphabetaTCR+CD4-CD8- T-cell deficiency and IDDM in NOD/Lt mice. , 1997, Diabetes.

[63]  D. Godfrey,et al.  Association Between αβTCR+CD4−CD8− T-Cell Deficiency and IDDM in NOD/Lt Mice , 1997, Diabetes.

[64]  D. Fearon,et al.  Innate immunity Innate pathways that control acquired immunity , 1997 .

[65]  A. Herbelin,et al.  Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse , 1996, European journal of immunology.

[66]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[67]  S. E. Brodie New York, New York, USA , 1996 .

[68]  K. Lafferty,et al.  The Th1/Th2 balance in autoimmunity. , 1995, Current opinion in immunology.

[69]  M. Toda,et al.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.

[70]  J. Yewdell,et al.  CD1 recognition by mouse NK1+ T lymphocytes. , 1995, Science.

[71]  L. Chess,et al.  Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. , 1995, Immunity.

[72]  R. Seder Acquisition of lymphokine-producing phenotype by CD4+ T cells. , 1994, The Journal of allergy and clinical immunology.

[73]  R. Cotter,et al.  Identification of a tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen , 1994, Cell.

[74]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[75]  R. Noelle,et al.  The role of CD40 in the regulation of humoral and cell-mediated immunity. , 1994, Immunology today.

[76]  Susumu Tonegawa,et al.  High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice , 1994, Cell.

[77]  H. Ochs,et al.  Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. , 1994, Journal of immunology.

[78]  C. Janeway,et al.  Signals and signs for lymphocyte responses , 1994, Cell.

[79]  Hong Jiang,et al.  Role of CD8+ T Cells in Murine Experimental Allergic Encephalomyelitis , 1992, Science.

[80]  T. Mak,et al.  Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice , 1992, Science.

[81]  S. Lederman,et al.  Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help) , 1992, The Journal of experimental medicine.

[82]  E. Clark,et al.  The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells , 1991, The Journal of experimental medicine.

[83]  J. Streilein,et al.  Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. , 1990, Immunology.

[84]  C. Janeway,et al.  Do Suppressor T Cells Exist? A Reply , 1988, Scandinavian journal of immunology.

[85]  G. Möller Do Suppressor T Cells Exist? , 1988, Scandinavian journal of immunology.

[86]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[87]  F. Alt,et al.  Regulation of Genome Rearrangement Events during Lymphocyte Differentiation , 1986, Immunological reviews.

[88]  K. Kuribayashi,et al.  Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease , 1985, The Journal of experimental medicine.

[89]  L. Chess,et al.  Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset. , 1982, Journal of immunology.

[90]  L. Chess,et al.  Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population , 1981, The Journal of experimental medicine.

[91]  J. Sosman,et al.  Functional analysis of human T cell subsets defined by monoclonal antibodies. I. Collaborative T-T interactions in the immunoregulation of B cell differentiation. , 1980, Journal of immunology.

[92]  Ellis L. Reinherz,et al.  The differentiation and function of human T lymphocytes , 1980, Cell.

[93]  H. Cantor,et al.  The Qa-1 antigenic system. Relation of Qa-1 phenotypes to lymphocyte sets, mitogen responses, and immune functions , 1978, The Journal of experimental medicine.

[94]  H. Cantor,et al.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition , 1978, The Journal of experimental medicine.

[95]  H. Cantor,et al.  Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses , 1976, The Journal of experimental medicine.

[96]  F. Burnet A modification of jerne's theory of antibody production using the concept of clonal selection , 1976, CA: a cancer journal for clinicians.

[97]  H. Cantor,et al.  Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen , 1975, The Journal of Experimental Medicine.

[98]  H. Cantor,et al.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity , 1975, The Journal of experimental medicine.

[99]  R. Gershon,et al.  Infectious immunological tolerance. , 1971, Immunology.

[100]  R. Gershon,et al.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes. , 1970, Immunology.

[101]  N. K. Jerne,et al.  THE NATURAL-SELECTION THEORY OF ANTIBODY FORMATION. , 1955, Proceedings of the National Academy of Sciences of the United States of America.

[102]  G. Martino,et al.  Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. , 2003, European journal of immunology.

[103]  V. Kuchroo,et al.  T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. , 2002, Annual review of immunology.

[104]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[105]  J. Casanova,et al.  X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy , 2001, Nature Genetics.

[106]  H. Ochs,et al.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.

[107]  L. Chess,et al.  Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. , 2001, Journal of immunology.

[108]  E. Shevach Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.

[109]  L. Chess,et al.  The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. , 2000, Annual review of immunology.

[110]  R. Flavell,et al.  Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. , 2000, Immunity.

[111]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[112]  A. Frey,et al.  NKT cell cytokine imbalance in murine diabetes mellitus. , 1999, Autoimmunity.

[113]  M. Bevan,et al.  Selecting and maintaining a diverse T-cell repertoire , 1999, Nature.

[114]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.

[115]  G. Prete The concept of type-1 and type-2 helper T cells and their cytokines in humans. , 1998 .

[116]  Mark M. Davis,et al.  LIGAND RECOGNITION BY T CELL RECEPTORS , 1998 .

[117]  J. Niederkorn,et al.  A novel role for TGF-beta and IL-10 in the induction of immune privilege. , 1998, Journal of immunology.

[118]  G. Del Prete,et al.  The concept of type-1 and type-2 helper T cells and their cytokines in humans. , 1998, International reviews of immunology.

[119]  D. Hafler,et al.  Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. , 1998, Nature.

[120]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.

[121]  D. Fearon,et al.  Innate pathways that control acquired immunity. , 1997, Current opinion in immunology.

[122]  M. Taniguchi,et al.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. , 1997, Science.

[123]  J Bajorath,et al.  Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.

[124]  A. Bendelac Mouse NK1+ T cells. , 1995, Current opinion in immunology.

[125]  J. Rodgers,et al.  Antigen presentation by major histocompatibility complex class I-B molecules. , 1994, Annual review of immunology.

[126]  D. Lancki,et al.  Differential regulation of murine T lymphocyte subsets. , 1993, Annual review of immunology.

[127]  B. Diamond,et al.  Revisiting and revising suppressor T cells. , 1992, Immunology today.

[128]  R. Coffman,et al.  CD4+ T-cell subsets: regulation of differentiation and function. , 1991, Research in immunology.

[129]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[130]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[131]  D. Green,et al.  Immunoregulatory T-cell pathways. , 1983, Annual review of immunology.

[132]  M. Cooper,et al.  Human lymphocyte subpopulations. , 1979, Progress in hematology.

[133]  L. Chess,et al.  Human lymphocyte subpopulations. , 1977, Advances in immunology.

[134]  Jerne Nk,et al.  The immune system: a web of V-domains. , 1974, Harvey lectures.

[135]  P. Ehrlich,et al.  Croonian lecture.—On immunity with special reference to cell life , 1900, Proceedings of the Royal Society of London.